The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto, which brought in nearly $2.4 billion in US sales last year. The US regulator has cleared 2.5mg ...
The UK is putting £80 million ($105 million) in funding behind nine technologies that it hopes will be able to diagnose dementia more quickly. Astellas Pharma US president Percival Barretto-Ko talks ...
In a country where affordable healthcare is a challenge, RHEA Generics has emerged as a leader in providing world-class, affordable medicines that Filipinos can trust. With the rising costs of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results